HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jourik A Gietema Selected Research

bleomycin hydrolase

4/2008Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
6/2005Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jourik A Gietema Research Topics

Disease

49Neoplasms (Cancer)
12/2021 - 02/2003
30Testicular Neoplasms (Testicular Cancer)
11/2021 - 06/2005
20Breast Neoplasms (Breast Cancer)
08/2021 - 01/2006
10Cardiotoxicity
01/2020 - 08/2005
9Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2021 - 06/2005
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2007
7Heart Failure
01/2020 - 02/2005
5Inflammation (Inflammations)
05/2021 - 01/2006
3Overweight
08/2021 - 02/2012
3Neutropenia
10/2020 - 10/2005
3Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 04/2016
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 04/2016
3Necrosis
01/2020 - 01/2006
3Disease Progression
10/2018 - 01/2015
3Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 10/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2016 - 06/2005
3Fever (Fevers)
01/2016 - 10/2005
2Neoplasm Metastasis (Metastasis)
10/2021 - 06/2005
2Seminoma
10/2021 - 01/2008
2Squamous Cell Carcinoma of Head and Neck
01/2020 - 01/2016
2Adenocarcinoma
01/2019 - 03/2003
2Pneumonia (Pneumonitis)
01/2016 - 06/2005
2Hodgkin Disease (Hodgkin's Disease)
01/2010 - 12/2009
2Bacterial Infections (Bacterial Infection)
10/2005 - 12/2003
2Febrile Neutropenia
10/2005 - 12/2003
1Cognitive Dysfunction
11/2021
1Hypogonadism (Hypergonadotropic Hypogonadism)
11/2021
1Nonseminomatous germ cell tumor
01/2021
1Ovarian Epithelial Carcinoma
10/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019

Drug/Important Bio-Agent (IBA)

22Cisplatin (Platino)FDA LinkGeneric
10/2021 - 12/2005
13Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2005
10AnthracyclinesIBA
01/2020 - 08/2005
9PlatinumIBA
01/2021 - 08/2010
8Pharmaceutical PreparationsIBA
01/2018 - 05/2004
8Bleomycin (Blenoxane)FDA LinkGeneric
01/2016 - 06/2005
7Trastuzumab (Herceptin)FDA Link
01/2020 - 05/2006
5Testosterone (Sustanon)FDA Link
11/2021 - 06/2005
5Etoposide (VP 16)FDA LinkGeneric
10/2021 - 10/2008
5DNA (Deoxyribonucleic Acid)IBA
05/2021 - 12/2012
4Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2006
4pro-brain natriuretic peptide (1-76)IBA
01/2018 - 05/2006
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021 - 10/2008
3Growth Differentiation Factor 15IBA
01/2020 - 01/2015
3LigandsIBA
01/2020 - 01/2006
3Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
10/2019 - 06/2004
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019 - 06/2017
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 06/2017
3Monoclonal AntibodiesIBA
10/2017 - 12/2007
389Zr-bevacizumabIBA
01/2017 - 06/2013
3human ERBB2 proteinIBA
08/2016 - 05/2006
2Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 05/2006
2Carboplatin (JM8)FDA LinkGeneric
10/2020 - 01/2020
2Metformin (Glucophage)FDA LinkGeneric
10/2020 - 09/2010
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2011
2Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 03/2015
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2019 - 10/2008
2ABT-767IBA
01/2019 - 10/2018
2Tyrosine Kinase InhibitorsIBA
12/2017 - 03/2015
2ErbB Receptors (EGF Receptor)IBA
10/2017 - 05/2006
2Hormones (Hormone)IBA
02/2016 - 06/2005
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 09/2015
2C-Reactive ProteinIBA
01/2016 - 01/2015
2Bevacizumab (Avastin)FDA Link
01/2015 - 06/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 01/2011
2von Willebrand FactorIBA
01/2015 - 12/2005
2Sunitinib (Sutent)FDA Link
01/2015 - 01/2011
2Sex Hormone-Binding GlobulinIBA
01/2014 - 06/2005
2Tumor Biomarkers (Tumor Markers)IBA
01/2011 - 10/2008
2Insulin (Novolin)FDA Link
09/2010 - 06/2005
2bleomycin hydrolaseIBA
04/2008 - 06/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007 - 01/2006
2Antineoplastic Agents (Antineoplastics)IBA
05/2006 - 01/2006
1RG7388IBA
12/2021
1PowdersIBA
12/2021
1Advanced Glycation End ProductsIBA
11/2021
1Peptide Hydrolases (Proteases)FDA Link
10/2021
1Peptides (Polypeptides)IBA
10/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2020
1tyramine-deoxysorbitolIBA
10/2020
13,6-dimethylaminodibenzopyriodonium citrateIBA
10/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2020
1sapanisertibIBA
01/2020
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020
1CXC ChemokinesIBA
01/2020
1Caspase 3 (Caspase-3)IBA
01/2020
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
01/2020
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1Proprotein Convertase 9IBA
01/2020
1Circulating Tumor DNAIBA
01/2019

Therapy/Procedure

41Drug Therapy (Chemotherapy)
10/2021 - 03/2003
16Aftercare (After-Treatment)
11/2021 - 04/2009
13Therapeutics
11/2021 - 02/2003
13Radiotherapy
01/2020 - 10/2007
4Combination Drug Therapy (Combination Chemotherapy)
07/2020 - 01/2009
2Laparotomy
07/2020 - 11/2019
1Bariatric Surgery
10/2021
1Ambulatory Care (Outpatient Care)
05/2021
1Operative Surgical Procedures
07/2020
1Chemoradiotherapy
01/2020